Status:

UNKNOWN

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Lead Sponsor:

Shanghai Zhongshan Hospital

Conditions:

Helicobacter Pylori Infection

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This multicenter randomized controlled clinical trial was conducted to compare the eradication efficacy and health economic benefits of individualized regimens based on HP drug resistance mutation gen...

Detailed Description

This multicenter randomized controlled clinical trial was conducted to compare the eradication efficacy and health economic benefits of individualized regimens based on HP drug resistance mutation gen...

Eligibility Criteria

Inclusion

  • Participate in the trial voluntarily, fully understand the trial, and sign the informed consent form (ICF).
  • 18-75 years old on the day of signing the ICF.
  • Helicobacter pylori infection confirmed by 13C-urea breath test or rapid urease test.

Exclusion

  • Patients with severe heart, lung, kidney, liver, blood, nerve, endocrine, and psychiatric diseases.
  • Subjects or guardians refused to participate in the trial.
  • Alcohol and/or drugs Abuse (addiction or dependence) or poor compliance with doctor's judgment.
  • Have taken antibiotics, bismuth, proton pump inhibitors or Chinese traditional medicine 4 weeks before treatment.
  • Pregnant or lactating women.
  • Active peptic ulcer.
  • allergic to drugs used in the trial.
  • any other circumstances that are not suitable for recruitment.

Key Trial Info

Start Date :

March 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

388 Patients enrolled

Trial Details

Trial ID

NCT05250050

Start Date

March 25 2022

End Date

March 1 2023

Last Update

March 18 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Shanghai, Shanghai Municipality, China, 200000

2

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China, 200032

3

Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality, China, 200040

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment | DecenTrialz